• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD¿ STEM CELL ENUMERATION; COUNTER, DIFFERENTIAL CELL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD¿ STEM CELL ENUMERATION; COUNTER, DIFFERENTIAL CELL Back to Search Results
Model Number 344563
Medical Device Problem Code Device Markings/Labelling Problem (2911)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/20/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the bd¿ stem cell enumeration was missing lot info on the packaging.The following information was provided by the initial reporter: it was reported by the customer that 344563_1285770_ missing lot no on the kit box.
 
Additional Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Additional Manufacturer Narrative
H6: investigation summary: scope of issue: the scope of issue is limited to part 344563 lot 1285770, stem cell enumeration kit (b)(4) tests.Problem statement: customer reported complaint on 20-dec-2021, kit box did not show lot number and expiration date.This happened on one qty and three qty were fine.Manufacturing defect trend: there are no quality notifications (qn-zm) for part 344563 related to the reported issue.Date range (date opened to 12 months back) is from 21-dec-2020 to 21-dec-2021.Root cause analysis: based on the investigation result, root cause was application of a label on the kit box that had not received lot specific data.Visual inspection also failed.Complaint history review: there is one complaint for this issue in part 344563, it is this complaint, parent (b)(4).Date range is from 21-dec-2020 to 21-dec-2021.Risk review: process failure mode effects analysis (pfmea) 10000525149 rev.01.Risk mitigation is sufficient.Hazard(s) identified? yes.Hazard #: not numbered; hazard : label has incomplete or illegible information; cause: dirty or worn print head, printer setup; harmful effects: wrong assay result or cannot run assay.Delay in testing.; severity:_7; probability: 2; risk index: 42; implementation: validated printers; risk control: pr003: visual inspection.Sample labels are attached to batch record.Effectiveness verification: not applicable; new hazard: no.; mitigation(s) sufficient: yes; batch history record (bhr) review: bhr for part 344563 lot 1285770 was reviewed.The materials met all the manufacturing specifications prior to release.Wi7197-03 rev.03 includes 6 copies of the kit label and those copies have correct lot number and expiration date.An inspection report dated 21-oct-2021 finds that the label has correct lot number and expiration date.Returned sample analysis: a photo is not requested because the provided powerpoint document with photos confirms the complaint.The provided powerpoint document shows 2 photos, one of a kit-box missing the required lot number and expiration date and barcodes, and one of a kit-box with the required marks.Retain sample analysis: from the retained sample of part 344563 lot 1285770, the kit label was inspected and the defect was not present.The correct lot number and expiration date were present.Labeling /packaging review: part 344563 lot 1285770 was reviewed.The materials met all the labeling / packaging specifications prior to release.Conclusion: based on the investigation result, complaint is confirmed.
 
Event or Problem Description
It was reported that the bd¿ stem cell enumeration was missing lot info on the packaging.The following information was provided by the initial reporter: it was reported by the customer that 344563_1285770_ missing lot no on the kit box.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD¿ STEM CELL ENUMERATION
Common Device Name
COUNTER, DIFFERENTIAL CELL
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13252992
Report Number2916837-2021-00522
Device Sequence Number14600798
Product Code GKZ
UDI-Device Identifier00382903445639
UDI-Public00382903445639
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
BK110037
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date08/31/2023
Device Model Number344563
Device Catalogue Number344563
Device Lot Number1285770
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/20/2021
Supplement Date Received by Manufacturer03/11/2022
Initial Report FDA Received Date01/13/2022
Supplement Report FDA Received Date03/21/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/12/2021
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-